Psyadon Pharmaceuticals, Inc.

Developing drugs to treat neurodegenerative diseases with an initial focus on dopamine receptors with first indication in Lesch-Nyhan Disease


Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current